Watch the Reel
Designing Cancer Drugs with Code
Exploring the world of AI in health innovation.
Why this matters
Understanding the intricacies of protein folding and binding.
When it comes to the intricate world of protein biology, the 3D structure of a protein often dictates its function. Proteins that do not fold correctly may fail to function as intended, or worse, cause disease. Scientists have long sought to understand and predict how proteins fold, a process that can take months or years experimentally. However, recent advancements in AI have dramatically accelerated this process, potentially revolutionizing fields like cancer treatment and immunology.
The journey to AI-accelerated protein design
Understanding protein folding
Imagine being able to design a cancer drug with the same precision as writing a line of code. This once-futuristic concept is now a reality, thanks to a recent breakthrough by Biohub. For decades, scientists have grappled with predicting how proteins fold, a critical step in understanding and manipulating their behavior. A protein's 3D shape determines its function, what it binds to, and whether it fights or causes disease. Getting the shape wrong can result in a drug that doesn't work, while getting it right can lead to powerful therapeutic agents.
From prediction to design
The quest to understand and predict protein folding has seen significant milestones. AlphaFold, developed by DeepMind, made waves in 2020 by solving the protein folding problem and winning the Nobel Prize in Chemistry. AlphaFold's success, however, was primarily in prediction. The more challenging aspect of the puzzle is design—engineering entirely new proteins that don't exist in nature to hit specific targets.
The ESM Atlas
Biohub has now cracked the design problem with their groundbreaking system, ESM Atlas. This system is a world model of protein biology, capable of mapping, predicting, and designing proteins on a scale never seen before. The ESM Atlas covers 6.8 billion protein sequences and 1.1 billion predicted structures. This vast dataset is the result of training a language model, ESMC, on 2.8 billion protein sequences from across all of life. ESMC didn't just learn what proteins look like; it grasped the fundamental "grammar" of biology.
The process
ESM Fold 2, a component of the ESM Atlas, takes the representations generated by ESMC and outputs atomically resolved 3D structures. This process uses a looped transformer architecture that scales efficiently at inference time. Researchers have already used this system to design protein binders against five cancer and immunology targets.
The computational search for these structures, which would have taken billions of years to generate experimentally, was completed in weeks. This staggering acceleration highlights the power of AI in accelerating scientific discovery. All three models—ESM Atlas, ESMC, and ESM Fold 2—are fully open source, allowing researchers worldwide to leverage this technology.
Practical tips for leveraging AI in protein design
Accessing the tools
To dive into the world of AI-accelerated protein design, start by exploring the resources available on Biohub's GitHub page. The open-source nature of the ESM Atlas, ESMC, and ESM Fold 2 models makes them accessible to researchers and enthusiasts alike.
Understanding the models
Familiarize yourself with the ESM language model, which has been trained on a vast dataset of protein sequences. Understanding how ESMC learns the "grammar" of biology can provide insights into how to harness its power for specific research questions. ESM Fold 2, with its looped transformer architecture, is particularly powerful for generating atomically resolved 3D structures.
Applying the technology
Consider how these tools can be applied to your research. Whether you're working in cancer treatment, immunology, or another field, the ability to design proteins with precision can open new avenues for discovery. Think about specific targets you might want to hit and how the ESM Atlas can help you design proteins to achieve that goal.
Important takeaways
The power of AI
AI has the potential to revolutionize fields like protein biology by accelerating the discovery process. The ability to map, predict, and design proteins at an unprecedented scale is a game-changer.
The role of open-source technology
The open-source nature of the ESM Atlas, ESMC, and ESM Fold 2 models democratizes access to this powerful technology. Researchers worldwide can leverage these tools to advance their work, fostering a collaborative and innovative scientific community.
The future of protein design
As AI continues to evolve, the future of protein design looks brighter than ever. The ability to engineer proteins with precision can lead to breakthroughs in cancer treatment, immunology, and beyond. By understanding and harnessing the power of these tools, researchers can push the boundaries of what's possible in protein biology.
Conclusion
AI-accelerated protein design is not just a futuristic concept—it's a reality that is already transforming fields like cancer treatment and immunology. By leveraging the power of the ESM Atlas, ESMC, and ESM Fold 2, researchers can design proteins with unprecedented precision, opening new avenues for discovery and innovation. As these tools become more accessible and powerful, the future of protein biology looks brighter than ever.
Key points
- Proteins' 3D structure determines their function, and incorrect folding can lead to disease or non-functional drugs.
- AI has significantly accelerated the process of understanding and predicting protein folding, which is crucial for fields like cancer treatment and immunology.
- Biohub's ESM Atlas is a world model of protein biology, capable of mapping, predicting, and designing proteins on an unprecedented scale.
- The ESM Atlas covers 6.8 billion protein sequences and 1.1 billion predicted structures, trained on 2.8 billion protein sequences from across all of life.
- ESM Fold 2, a component of the ESM Atlas, generates atomically resolved 3D structures using a looped transformer architecture that scales efficiently.
- Researchers have used the ESM Atlas to design protein binders against five cancer and immunology targets in a matter of weeks, a process that would have taken billions of years experimentally.
FAQ
Biohub's AI breakthrough allows scientists to design proteins with the same precision as writing code. This means that researchers can specify exactly how a protein should fold and bind, leading to more effective and targeted treatments, such as cancer drugs. By using AI, the process of protein design becomes more efficient and less reliant on trial and error, which has huge implications for drug discovery.
AI-designed proteins can accelerate cancer treatment development by predicting and creating proteins that do not exist in nature. These custom-designed proteins can target specific cancer cells, potentially reducing side effects and improving treatment efficacy. Additionally, AI can help in understanding the intricate world of protein foldings and bindings. By understanding these processes, scientists can develop more effective cancer treatments.
AI technologies can dramatically speed up the process of protein structure prediction, which traditionally can take months or even years. By using AI, scientists can now simulate and predict how a protein will fold much more quickly, allowing for faster advancements in protein engineering and drug development. This acceleration is crucial for fields like cancer treatment and immunology, where time is of the essence.
Absolutely. While cancer treatment is a significant area of focus, AI-designed proteins have the potential to revolutionize many other fields. Immunology, for instance, could benefit greatly from custom-designed proteins that enhance the body's immune response. Additionally, AI protein engineering could lead to advancements in regenerative medicine, biofuels, and even agriculture by creating proteins with specific functions tailored to these industries.
Protein folding is crucial in drug development because the 3D structure of a protein often determines its function. If a protein doesn't fold correctly, it may not function as intended or could even cause disease. Understanding and predicting protein folding allows scientists to design drugs that interact with proteins in the desired way, ensuring that the drug is effective and has minimal side effects. Biohub's AI innovation accelerates this understanding by providing precise models of protein structures.
Biohub's AI technology offers a significant advantage over traditional protein design methods by providing a level of precision and speed that was previously unattainable. Traditional methods often rely on extensive experimentation and can take a long time to yield results. In contrast, AI allows for the design of proteins with code-like precision, enabling researchers to predict and create proteins that do not exist in nature, ultimately accelerating the development of new drugs and treatments.
Beyond drug development, AI in protein research has wide-ranging implications. It can enhance our understanding of biological processes, improve the efficiency of protein engineering, and facilitate the creation of bio-based materials. By enabling precise protein design, AI can lead to innovations in various fields, including materials science, environmental sustainability, and even food production. The ability to design proteins with specific functions opens up new possibilities for addressing complex challenges.
Share this article
Related deep dives
Similar reads based on topic and creator.
Recent articles
Fresh deep dives from the latest Reels we unpacked.
Comments
Be the first to comment.